Andrew Karter to Dementia
This is a "connection" page, showing publications Andrew Karter has written about Dementia.
Connection Strength
1.371
-
Changes in Medication Use After Dementia Diagnosis in an Observational Cohort of Individuals with Diabetes Mellitus. J Am Geriatr Soc. 2017 01; 65(1):77-82.
Score: 0.444
-
GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
Score: 0.206
-
Glycemic Control Over Multiple Decades and Dementia Risk in People With Type 2 Diabetes. JAMA Neurol. 2023 06 01; 80(6):597-604.
Score: 0.176
-
Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes. Diabetes Care. 2018 11; 41(11):2339-2345.
Score: 0.127
-
Severe diabetic retinal disease and dementia risk in type 2 diabetes. J Alzheimers Dis. 2014; 42 Suppl 3:S109-17.
Score: 0.092
-
Racial/ethnic differences in dementia risk among older type 2 diabetic patients: the diabetes and aging study. Diabetes Care. 2014 Apr; 37(4):1009-15.
Score: 0.091
-
Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013 Nov; 1(3):183-90.
Score: 0.090
-
Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry. 2012 Apr; 69(4):410-7.
Score: 0.080
-
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009 Apr 15; 301(15):1565-72.
Score: 0.066